Express Pharma
Verified
Magazine
Express Pharma, first published as Express Pharma Pulse in 1994, is today India’s leading business fortnightly for the pharmaceutical industry. With the patronage of its readers, Express Pharma has grown to become the No.1 Business News Magazine for the pharmaceutical industry. The editorial contents include: news, views, analysis and interviews, under four main segments: Market (The business of pharmaceuticals), Management (Insight for managing pharma), Research (Expertise for drug development) and Pharma Life (HR issues with a pharma focus). Besides this, we bring out periodic specials like the quarterly Pharma Technology Review, Packaging Special and LABNEXT. Source
Actions
Media Outlet details
| Scope | National |
|---|---|
| Language | English |
| Country | India |
Similarweb UVM
|
Request pricing |
Comscore UVM
|
Request pricing |
Recent Articles
Search ArticlesACG appoints Lalit Kasliwal as Group Chief Financial Officer
Share ACG has appointed Lalit Kasliwal as Group Chief Financial Officer, with responsibility for the company’s global finance function across its pharmaceutical and nutraceutical manufacturing businesses. In his new role, Kasliwal will lead financial strategy, treasury, governance, capital allocation and risk management to support ACG’s long-term ambitions.
An effective methodology for diabetes prediction in the case of class imbalance
Share This article draws on peer-reviewed research conducted at SP Jain School of Global Management and published in Bioengineering (2025, 12, 35). The study develops a novel machine learning methodology for diabetes prediction that outperforms existing algorithms when clinical data suffer from class imbalance. The clinical stakes of getting prediction right Diabetes remains one of the most consequential public health challenges worldwide.
Godavari Biorefineries secures European patent for pharma composition
Share Godavari Biorefineries has secured a patent from the European Patent Office for its invention, “Pharmaceutical Composition and a Process to Prepare the Same”. The patent covers a pharmaceutical composition that combines anti-cancer compounds with a solubilising agent, along with the process to prepare it. The composition is designed to enhance the solubility and bioavailability of the active compounds, thereby improving their therapeutic potential.
Optimus Pharma gets DCGI permission for Tapinarof Cream 1% w/w
Share Optimus Pharma, a subsidiary of Sekhmet Pharmaventures, has become the first company in India to receive permission from the Drugs Controller General of India (DCGI) to manufacture and market Tapinarof Cream 1 per cent w/w and the tapinarof bulk drug. Tapinarof Cream 1 per cent w/w is a non-steroidal topical treatment for plaque psoriasis in adults.
ACG appoints Rajesh Bhogavalli as Group Chief Commercial Officer
Share ACG has appointed Rajesh Bhogavalli as Group Chief Commercial Officer as the company continues its international growth, operational excellence and commercial transformation across its pharmaceutical and nutraceutical manufacturing businesses. As Group Chief Commercial Officer, Bhogavalli will lead the Group’s global commercial strategy, strengthen strategic partnerships, drive cost-optimisation initiatives and support market expansion.
Lupin receives USFDA approval for Pitolisant Tablets
Share Lupin has received final approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug Application for Pitolisant Tablets, 4.45 mg and 17.8 mg. The U.S. FDA has approved Lupin’s Pitolisant Tablets, 4.45 mg and 17.8 mg, as bioequivalent to Wakix for the indications in the approved labelling. Lupin PharmaceuticalsLupin Pitolisant TabletsPitolisant 17.8 mgPitolisant 4.45 mgUSFDA approval Share
USFDA classifies Aurobindo Pharma’s Raleigh plant as VAI
Share Aurobindo Pharma said the United States Food and Drug Administration (USFDA) has classified its Raleigh plant in North Carolina, USA, as “Voluntary Action Indicated” (VAI) following an inspection conducted in 2025. Pursuant to Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, the company said the USFDA inspected the Raleigh plant from March 24, 2025, to April 10, 2025.
TCS launches ADD AgentHub for agentic AI in drug development
Share Tata Consultancy Services (TCS) has launched TCS ADD AgentHub, a role-based, enterprise-ready and trusted AI platform that enables the use of agentic AI in drug development at scale. The platform is designed to transform clinical trials and pharmacovigilance services while maintaining regulatory and audit requirements. Pharmaceutical companies operate in regulated environments and face challenges related to trust, governance and scalability when applying AI across functions.
75th IPC to be held in New Delhi in December 2026
Share The 75th Indian Pharmaceutical Congress (IPC) will be held from 18-20 December 2026 at the Yashobhoomi Convention Centre, Sector 25, Dwarka, New Delhi. The Platinum Jubilee edition is being organised by the Indian Pharmaceutical Congress Association (IPCA) and the Indian Pharmacy Graduates’ Association (IPGA). The theme of IPC 2026 is “Transforming India from Pharmacy of the World to Pharma Powerhouse @2047”, aligned with the national vision of Viksit Bharat – Viksit Pharmacy.
LSSSDC to organise Skillverse 2026 National Skill Summit in Hyderabad
Share The Life Sciences Sector Skill Development Council (LSSSDC), operating under the aegis of the Ministry of Skill Development & Entrepreneurship (MSDE), Government of India, will organise ‘LSSSDC Skillverse 2026’, a National Skill Summit for the Life Sciences sector, on 21st August 2026 at Hotel Le Méridien, Hyderabad.